138 related articles for article (PubMed ID: 2952686)
1. Expression of human lymphocyte antigen (HLA)-DR on tumor cells in basal cell carcinoma.
Kohchiyama A; Oka D; Ueki H
J Am Acad Dermatol; 1987 Apr; 16(4):833-8. PubMed ID: 2952686
[TBL] [Abstract][Full Text] [Related]
2. Immunohistologic studies of squamous cell carcinoma: possible participation of Leu-7+ (natural killer) cells as antitumor effector cells.
Kohchiyama A; Oka D; Ueki H
J Invest Dermatol; 1986 Oct; 87(4):515-8. PubMed ID: 3093594
[TBL] [Abstract][Full Text] [Related]
3. Intralesional T lymphocyte phenotypes and HLA-DR expression in Melkersson-Rosenthal syndrome.
Rönnblom L; Forsum U; Evrin PE; Gillnäs T; Nethander G
Int J Oral Maxillofac Surg; 1986 Oct; 15(5):614-9. PubMed ID: 3097189
[TBL] [Abstract][Full Text] [Related]
4. An absence of human leukocyte antigen-DR and a decreased expression of beta 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate.
Habets JM; Tank B; Vuzevski VD; Stolz E; van Joost T
J Am Acad Dermatol; 1989 Jan; 20(1):47-52. PubMed ID: 2521495
[TBL] [Abstract][Full Text] [Related]
5. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
Schmitt D; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
[TBL] [Abstract][Full Text] [Related]
6. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
[TBL] [Abstract][Full Text] [Related]
7. Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression.
Buechner SA
J Am Acad Dermatol; 1991 May; 24(5 Pt 1):731-4. PubMed ID: 1869644
[TBL] [Abstract][Full Text] [Related]
8. OKT4+ T cell abnormality in patients with active systemic lupus erythematosus: HLA-DR antigen expressions.
Raziuddin S; Danial HB; Kelley M
Clin Immunol Immunopathol; 1988 Jul; 48(1):42-9. PubMed ID: 3260161
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions.
Kageshita T; Ono T; Hirai S; Yoshii A; Kimura T; Nakakuma H; Horikawa K; Takatsuki K; Ferrone S
Cancer Res; 1992 Jun; 52(11):3201-7. PubMed ID: 1350511
[TBL] [Abstract][Full Text] [Related]
10. In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations.
Czernielewski J; Faure M; Schmitt D; Thivolet J
Clin Exp Immunol; 1982 Nov; 50(2):426-33. PubMed ID: 6217936
[TBL] [Abstract][Full Text] [Related]
11. HLA and multiple skin carcinomas.
Cerimele D; Contu L; Carcassi C; Costa G; La Nasa G; Sanna E; Campus GV
Dermatologica; 1988; 176(4):176-81. PubMed ID: 3378654
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours.
Markey AC; Churchill LJ; MacDonald DM
J Cutan Pathol; 1990 Apr; 17(2):65-71. PubMed ID: 2187024
[TBL] [Abstract][Full Text] [Related]
13. Expression of activation antigens by T cells infiltrating basal cell carcinomas.
Guillén FJ; Day CL; Murphy GF
J Invest Dermatol; 1985 Sep; 85(3):203-6. PubMed ID: 3875662
[TBL] [Abstract][Full Text] [Related]
14. Pattern of distribution of T lymphocytes, Langerhans cells and HLA-DR bearing cells in normal human oral mucosa.
Reibel J; Dabelsteen E; Kenrad B; Buschard K
Scand J Dent Res; 1985 Dec; 93(6):513-21. PubMed ID: 2937133
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytic response to basal-cell carcinoma: in situ identification of functional subsets using monoclonal antibodies.
Eaglstein NF; Hernandez AD; Allen JE
J Dermatol Surg Oncol; 1982 Nov; 8(11):943-7. PubMed ID: 6217236
[No Abstract] [Full Text] [Related]
16. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
17. Expression of HLA-DR and OKT6 antigens on keratinocytes and dendritic cells in pemphigus.
Picut C; Meunier J; Lee C; Lewis R
Arch Dermatol Res; 1987; 279(8):516-20. PubMed ID: 2449139
[TBL] [Abstract][Full Text] [Related]
18. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
Aichinger G; Fill H; Wick G
Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
[TBL] [Abstract][Full Text] [Related]
19. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte subsets and activation antigens in a reference population: a flow cytometric study using single and double antibody staining.
Schuerch C; Fleetwood M; Glidewell O
Immunol Invest; 1987 Jun; 16(4):345-60. PubMed ID: 2828230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
